259 related articles for article (PubMed ID: 21697492)
1. Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway.
Deng L; Shoji I; Ogawa W; Kaneda S; Soga T; Jiang DP; Ide YH; Hotta H
J Virol; 2011 Sep; 85(17):8556-68. PubMed ID: 21697492
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of hepatitis C virus-induced glucose metabolic disorders.
Shoji I; Deng L; Hotta H
Front Microbiol; 2011; 2():278. PubMed ID: 22291689
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus NS5A protein enhances gluconeogenesis through upregulation of Akt-/JNK-PEPCK signalling pathways.
Kuo YC; Chen IY; Chang SC; Wu SC; Hung TM; Lee PH; Shimotohno K; Chang MF
Liver Int; 2014 Oct; 34(9):1358-68. PubMed ID: 25360475
[TBL] [Abstract][Full Text] [Related]
4. Increased phosphoenolpyruvate carboxykinase gene expression and steatosis during hepatitis C virus subgenome replication: role of nonstructural component 5A and CCAAT/enhancer-binding protein β.
Qadri I; Choudhury M; Rahman SM; Knotts TA; Janssen RC; Schaack J; Iwahashi M; Puljak L; Simon FR; Kilic G; Fitz JG; Friedman JE
J Biol Chem; 2012 Oct; 287(44):37340-51. PubMed ID: 22955269
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus NS5A promotes insulin resistance through IRS-1 serine phosphorylation and increased gluconeogenesis.
Parvaiz F; Manzoor S; Iqbal J; Sarkar-Dutta M; Imran M; Waris G
World J Gastroenterol; 2015 Nov; 21(43):12361-9. PubMed ID: 26604643
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expression.
Banerjee A; Meyer K; Mazumdar B; Ray RB; Ray R
J Virol; 2010 Jun; 84(12):5936-46. PubMed ID: 20357092
[TBL] [Abstract][Full Text] [Related]
7. GCN5L1 modulates cross-talk between mitochondria and cell signaling to regulate FoxO1 stability and gluconeogenesis.
Wang L; Scott I; Zhu L; Wu K; Han K; Chen Y; Gucek M; Sack MN
Nat Commun; 2017 Sep; 8(1):523. PubMed ID: 28900165
[TBL] [Abstract][Full Text] [Related]
8. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
[TBL] [Abstract][Full Text] [Related]
9. Forkhead box transcription factor regulation and lipid accumulation by hepatitis C virus.
Bose SK; Kim H; Meyer K; Wolins N; Davidson NO; Ray R
J Virol; 2014 Apr; 88(8):4195-203. PubMed ID: 24478438
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus induces a prediabetic state by directly impairing hepatic glucose metabolism in mice.
Lerat H; Imache MR; Polyte J; Gaudin A; Mercey M; Donati F; Baudesson C; Higgs MR; Picard A; Magnan C; Foufelle F; Pawlotsky JM
J Biol Chem; 2017 Aug; 292(31):12860-12873. PubMed ID: 28559285
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of gluconeogenesis in primary hepatocytes by stromal cell-derived factor-1 (SDF-1) through a c-Src/Akt-dependent signaling pathway.
Liu HY; Wen GB; Han J; Hong T; Zhuo D; Liu Z; Cao W
J Biol Chem; 2008 Nov; 283(45):30642-9. PubMed ID: 18786922
[TBL] [Abstract][Full Text] [Related]
12. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
[TBL] [Abstract][Full Text] [Related]
13. Regulation of glucose metabolism via hepatic forkhead transcription factor 1 (FoxO1) by Morinda citrifolia (noni) in high-fat diet-induced obese mice.
Nerurkar PV; Nishioka A; Eck PO; Johns LM; Volper E; Nerurkar VR
Br J Nutr; 2012 Jul; 108(2):218-228. PubMed ID: 22011624
[TBL] [Abstract][Full Text] [Related]
14. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
15. Mapping MKP-3/FOXO1 interaction and evaluating the effect on gluconeogenesis.
Jiao P; Feng B; Xu H
PLoS One; 2012; 7(7):e41168. PubMed ID: 22848439
[TBL] [Abstract][Full Text] [Related]
16. GSK3β regulates gluconeogenic gene expression through HNF4α and FOXO1.
Sakamaki J; Daitoku H; Kaneko Y; Hagiwara A; Ueno K; Fukamizu A
J Recept Signal Transduct Res; 2012 Apr; 32(2):96-101. PubMed ID: 22384829
[TBL] [Abstract][Full Text] [Related]
17. Endoplasmic reticulum stress links hepatitis C virus RNA replication to wild-type PGC-1α/liver-specific PGC-1α upregulation.
Yao W; Cai H; Li X; Li T; Hu L; Peng T
J Virol; 2014 Aug; 88(15):8361-74. PubMed ID: 24829353
[TBL] [Abstract][Full Text] [Related]
18. Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication.
Sun LJ; Yu JW; Wan L; Zhang XY; Shi YG; Chen MY
Int J Infect Dis; 2014 Jun; 23():75-81. PubMed ID: 24704332
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rg1 Inhibits Glucagon-Induced Hepatic Gluconeogenesis through Akt-FoxO1 Interaction.
Liu Q; Zhang FG; Zhang WS; Pan A; Yang YL; Liu JF; Li P; Liu BL; Qi LW
Theranostics; 2017; 7(16):4001-4012. PubMed ID: 29109794
[No Abstract] [Full Text] [Related]
20. Resveratrol attenuates dapagliflozin-induced renal gluconeogenesis
Sun X; Cao Z; Ma Y; Shao Y; Zhang J; Yuan G; Guo X
Food Funct; 2021 Feb; 12(3):1207-1218. PubMed ID: 33432947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
